BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12746229)

  • 1. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
    Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
    Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
    Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
    Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
    Siehler S; Zupanc GK; Seuwen K; Hoyer D
    Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
    Cervia D; Langenegger D; Schuepbach E; Cammalleri M; Schoeffter P; Schmid HA; Bagnoli P; Hoyer D
    Neuropharmacology; 2005 May; 48(6):881-93. PubMed ID: 15829258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
    Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
    Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs.
    Cervia D; Fehlmann D; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):578-87. PubMed ID: 12750875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
    Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
    J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J; Raulf F; Hoyer D; Bruns C
    Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
    Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
    Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S; Seuwen K; Hoyer D
    Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
    Erchegyi J; Hoeger CA; Low W; Hoyer D; Waser B; Eltschinger V; Schaer JC; Cescato R; Reubi JC; Rivier JE
    J Med Chem; 2005 Jan; 48(2):507-14. PubMed ID: 15658864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin sst2 receptor knock-out mice: localisation of sst1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography.
    Hannon JP; Petrucci C; Fehlmann D; Viollet C; Epelbaum J; Hoyer D
    Neuropharmacology; 2002 Mar; 42(3):396-413. PubMed ID: 11897118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of somatostatin and cortistatin receptors.
    Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
    Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterisation of the goldfish somatostatin sst5 receptor.
    Nunn C; Feuerbach D; Lin X; Peter R; Hoyer D
    Eur J Pharmacol; 2002 Feb; 436(3):173-86. PubMed ID: 11858797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.